Third‐generation oncolytic herpes simplex virus inhibits the growth of liver tumors in mice

Multimodality therapies are used to manage patients with hepatocellular carcinoma (HCC), although advanced HCC is incurable. Oncolytic virus therapy is probably the next major breakthrough in cancer treatment. The third‐generation oncolytic herpes simplex virus type 1 (HSV‐1) T‐01 kills tumor cells...

Descripción completa

Detalles Bibliográficos
Autores principales: Nakatake, Richi, Kaibori, Masaki, Nakamura, Yusuke, Tanaka, Yoshito, Matushima, Hideyuki, Okumura, Tadayoshi, Murakami, Takashi, Ino, Yasushi, Todo, Tomoki, Kon, Masanori
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5834814/
https://www.ncbi.nlm.nih.gov/pubmed/29288515
http://dx.doi.org/10.1111/cas.13492

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5834814/
https://www.ncbi.nlm.nih.gov/pubmed/29288515
http://dx.doi.org/10.1111/cas.13492

Ejemplares similares